DFS vs SRNE
DFS (DFS) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
DFS (DFS) common stock.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
DFS does not have a complete income-statement cache yet.
SRNE does not have a complete income-statement cache yet.
SRNE currently screens at market cap $385.9K.
Not investment advice. Open the DFS and SRNE stock pages for the full models.
Not investment advice.